4//SEC Filing
Berger Mark Stanley 4
Accession 0001213900-21-046687
CIK 0001388320other
Filed
Sep 2, 8:00 PM ET
Accepted
Sep 3, 5:04 PM ET
Size
5.7 KB
Accession
0001213900-21-046687
Insider Transaction Report
Form 4
Berger Mark Stanley
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-09-01+67,164→ 67,164 totalExercise: $6.07Exp: 2031-09-01→ Common Stock (67,164 underlying)
Footnotes (2)
- [F1]This price represents the closing price of the Company's common stock on the date of the board of directors approval of the grant.
- [F2]Pursuant to the terms of the Company's Amended and Restated 2013 Stock Plan and 2019 Stock Plan, 2% of the options will vest each month from September 1, 2021 until fully vested.
Documents
Issuer
Actinium Pharmaceuticals, Inc.
CIK 0001388320
Entity typeother
Related Parties
1- filerCIK 0001700283
Filing Metadata
- Form type
- 4
- Filed
- Sep 2, 8:00 PM ET
- Accepted
- Sep 3, 5:04 PM ET
- Size
- 5.7 KB